These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 31489987)

  • 21. Bioinformatic identification of chemoresistance-associated microRNAs in breast cancer based on microarray data.
    Wang YW; Zhang W; Ma R
    Oncol Rep; 2018 Mar; 39(3):1003-1010. PubMed ID: 29328395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA expression as risk biomarker of breast cancer metastasis: a pilot retrospective case-cohort study.
    Marino AL; Evangelista AF; Vieira RA; Macedo T; Kerr LM; Abrahão-Machado LF; Longatto-Filho A; Silveira HC; Marques MM
    BMC Cancer; 2014 Oct; 14():739. PubMed ID: 25277099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Computational Identification of Sex-Biased Biomarker MicroRNAs and Genes Associated with Immune Infiltration in Breast Cancer.
    Li EW; Bai Y
    Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33919884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
    Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
    J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BCL2 and hsa-miR-181a-5p are potential biomarkers associated with papillary thyroid cancer based on bioinformatics analysis.
    Zhang C; Bo C; Guo L; Yu P; Miao S; Gu X
    World J Surg Oncol; 2019 Dec; 17(1):221. PubMed ID: 31842912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of Heat Shock Proteins by miRNAs in human breast cancer.
    Ozgur A; Tutar L; Tutar Y
    Microrna; 2014; 3(2):118-35. PubMed ID: 25541910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identifying the miRNA signature associated with survival time in patients with lung adenocarcinoma using miRNA expression profiles.
    Yerukala Sathipati S; Ho SY
    Sci Rep; 2017 Aug; 7(1):7507. PubMed ID: 28790336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The highly expressed 5'isomiR of hsa-miR-140-3p contributes to the tumor-suppressive effects of miR-140 by reducing breast cancer proliferation and migration.
    Salem O; Erdem N; Jung J; Münstermann E; Wörner A; Wilhelm H; Wiemann S; Körner C
    BMC Genomics; 2016 Aug; 17():566. PubMed ID: 27502506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bioinformatics analysis of microRNA comprehensive regulatory network in B- cell acute lymphoblastic leukemia].
    Zeng MN; Ma WL; Zheng WL
    Zhonghua Xue Ye Xue Za Zhi; 2016 Jul; 37(7):585-90. PubMed ID: 27535859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CeNETs analysis reveals the prognostic value of a signature integration from five lncRNAs in breast cancer.
    Wang K; Liao C; Zhong Q; Dong H; Zhang T; Jin R
    J Cell Biochem; 2019 Aug; 120(8):13509-13519. PubMed ID: 30927387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA hsa-mir-3923 serves as a diagnostic and prognostic biomarker for gastric carcinoma.
    Yang X; Zhang Z; Zhang L; Zhou L
    Sci Rep; 2020 Mar; 10(1):4672. PubMed ID: 32170105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circular RNA hsa_circ_0000376 Participates in Tumorigenesis of Breast Cancer by Targeting miR-1285-3p.
    Peng Z; Xu B; Jin F
    Technol Cancer Res Treat; 2020; 19():1533033820928471. PubMed ID: 32462972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of miRNA-Based Signature as a Novel Potential Prognostic Biomarker in Patients with Breast Cancer.
    Tang J; Ma W; Zeng Q; Tan J; Cao K; Luo L
    Dis Markers; 2019; 2019():3815952. PubMed ID: 31976020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Five miRNAs considered as molecular targets for predicting neuroglioma.
    Yang H; Wang Y
    Tumour Biol; 2016 Jan; 37(1):1051-9. PubMed ID: 26269115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of differentially expressed novel miRNAs in breast normal cells and their putative targets.
    Shuaib M; Prajapati KS; Singh AK; Kumar S
    Mol Cell Biochem; 2023 Oct; 478(10):2361-2378. PubMed ID: 36680668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioinformatics method to predict two regulation mechanism: TF-miRNA-mRNA and lncRNA-miRNA-mRNA in pancreatic cancer.
    Ye S; Yang L; Zhao X; Song W; Wang W; Zheng S
    Cell Biochem Biophys; 2014 Dec; 70(3):1849-58. PubMed ID: 25087086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Novel Necroptosis-Related miRNA Signature for Predicting the Prognosis of Breast Cancer Metastasis.
    Zheng L; Wang J; Jiang H; Dong H
    Dis Markers; 2022; 2022():3391878. PubMed ID: 35371342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Biomarkers for Non-functioning Invasive Pituitary Adenomas were Identified by Using Analysis of microRNAs Expression Profile.
    Wu S; Gu Y; Huang Y; Wong TC; Ding H; Liu T; Zhang Y; Zhang X
    Biochem Genet; 2017 Jun; 55(3):253-267. PubMed ID: 28315020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of differential expression profile of miRNA in peripheral blood of patients with lung cancer.
    He Q; Fang Y; Lu F; Pan J; Wang L; Gong W; Fei F; Cui J; Zhong J; Hu R; Liang M; Fang L; Wang H; Yu M; Zhang ZF
    J Clin Lab Anal; 2019 Nov; 33(9):e23003. PubMed ID: 31541491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
    Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
    BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.